ddAC-THP
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ddAC-THP, covering 2026-06-09 to 2026-06-09. Get the full timeline:
Most recent: Clinical Trial Update: Trastuzumab Deruxtecan (T-DXd) Alone or in Sequence With THP, Versus Standard Treatment (ddAC-THP), in HER2-positive Early Breast Cancer [Phase 3]